Tendon progenitor cells in injured tendons have strong chondrogenic potential: The cd105-negative subpopulation induces chondrogenic degeneration

Stem Cells

Volumn 32, Issue 12, 2014, Pages 3266-3277

  Asai, Shuji ^a   Otsuru, Satoru ^a,c   Candela, Maria Elena ^a   Cantley, Leslie ^a   Uchibe, Kenta ^a   Hofmann, Ted J ^a   Zhang, Kairui ^a   Wapner, Keith L ^d   Soslowsky, Louis J ^e   Horwitz, Edwin M ^a,b,c   Enomoto Iwamoto, Motomi ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chondrogenesis; Injury; Progenitor; Tendon; TGF

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CELL SURFACE MARKER; TRANSFORMING GROWTH FACTOR BETA; ENDOGLIN PROTEIN, MOUSE; SIGNAL PEPTIDE;

ACHILLES TENDON; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW STROMA CELL; CARTILAGINOUS TISSUE; CD105 NEGATIVE CELL; CELL DEGENERATION; CELL DENSITY; CELL ISOLATION; CELL TRANSDIFFERENTIATION; CELL TYPE; CHONDROGENESIS; COLONY FORMING CELL; COLONY FORMING UNIT; CONNECTIVE TISSUE CELL; ENCHONDRAL OSSIFICATION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; MONOLAYER CULTURE; MOUSE; NONHUMAN; PHENOTYPE; STEM CELL; STEM CELL TRANSPLANTATION; TENDON INJURY; TENDON RECONSTRUCTION; TENDON STEM CELL; ANIMAL; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; TENDON;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CHONDROGENESIS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STROMAL CELLS; MICE; OSTEOGENESIS; STEM CELLS; TENDONS;

EID: 84912094438     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1847     Document Type: Article

References (43)

1. Sharma P, Maffulli N,. Tendon injury and tendinopathy: Healing and repair. J Bone Joint Surg Am 2005; 87: 187-202.
2. Rees JD, Wilson AM, Wolman RL,. Current concepts in the management of tendon disorders. Rheumatology (Oxford) 2006; 45: 508-521.
3. Aslan H, Kimelman-Bleich N, Pelled G, et al. Molecular targets for tendon neoformation. J Clin Invest 2008; 118: 439-444.
4. Tozer S, Duprez D,. Tendon and ligament: Development, repair and disease. Birth Defects Res C Embryo Today 2005; 75: 226-236.
5. Manske PR, Gelberman RH, Vande Berg JS, et al. Intrinsic flexor-tendon repair. A morphological study in vitro. J Bone Joint Surg Am 1984; 66: 385-396.
6. Gelberman RH, Manske PR, Vande Berg JS, et al. Flexor tendon repair in vitro: A comparative histologic study of the rabbit, chicken, dog, and monkey. J Orthop Res 1984; 2: 39-48.
7. Yin Z, Chen X, Chen JL, et al. The regulation of tendon stem cell differentiation by the alignment of nanofibers. Biomaterials 2010; 31: 2163-2175.
8. Zhang J, Wang JH,. Characterization of differential properties of rabbit tendon stem cells and tenocytes. BMC Musculoskelet Disord 2010; 11: 10.
9. Zhang J, Wang JH,. BMP-2 mediates PGE(2)-induced reduction of proliferation and osteogenic differentiation of human tendon stem cells. J Orthop Res 2012; 30: 47-52.
10. Rui YF, Lui PP, Li G, et al. Isolation and characterization of multipotent rat tendon-derived stem cells. Tissue Eng Part A 2010; 16: 1549-1558.
11. Bi Y, Ehirchiou D, Kilts TM, et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 2007; 13: 1219-1227.
12. Zhang J, Wang JH,. Platelet-rich plasma releasate promotes differentiation of tendon stem cells into active tenocytes. Am J Sports Med 2010; 38: 2477-2486.
13. Zhang J, Pan T, Liu Y, et al. Mouse treadmill running enhances tendons by expanding the pool of tendon stem cells (TSCs) and TSC-related cellular production of collagen. J Orthop Res 2010; 28: 1178-1183.
14. Medici D, Shore EM, Lounev VY, et al. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 2010; 16: 1400-1406.
15. Lounev VY, Ramachandran R, Wosczyna MN, et al. Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am 2009; 91: 652-663.
16. Lee SY, Miwa M, Sakai Y, et al. Isolation and characterization of connective tissue progenitor cells derived from human fracture-induced hemarthrosis in vitro. J Orthop Res 2008; 26: 190-199.
17. Matsumoto T, Mifune Y, Kawamoto A, et al. Fracture induced mobilization and incorporation of bone marrow-derived endothelial progenitor cells for bone healing. J Cell Physiol 2008; 215: 234-242.
18. Kurth TB, Dell'accio F, Crouch V, et al. Functional mesenchymal stem cell niches in adult mouse knee joint synovium in vivo. Arthritis Rheum 2011; 63: 1289-1300.
19. Koelling S, Kruegel J, Irmer M, et al. Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. Cell Stem Cell 2009; 4: 324-335.
20. Liu R, Birke O, Morse A, et al. Myogenic progenitors contribute to open but not closed fracture repair. BMC Musculoskelet Disord 2011; 12: 288.
21. Park D, Spencer JA, Koh BI, et al. Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell 2012; 10: 259-272.
22. Schindeler A, Liu R, Little DG,. The contribution of different cell lineages to bone repair: Exploring a role for muscle stem cells. Differentiation 2009; 77: 12-18.
23. Dominici M, Tadjali M, Kepes S, et al. Transgenic mice with pancellular enhanced green fluorescent protein expression in primitive hematopoietic cells and all blood cell progeny. Genesis 2005; 42: 17-22.
24. Schweitzer R, Chyung JH, Murtaugh LC, et al. Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development 2001; 128: 3855-3866.
25. Shimono K, Morrison TN, Tung WE, et al. Inhibition of ectopic bone formation by a selective retinoic acid receptor alpha-agonist: A new therapy for heterotopic ossification? J Orthop Res 2010; 28: 271-277.
26. Otsuru S, Gordon PL, Shimono K, et al. Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms. Blood 2012; 120: 1933-1941.
27. Otsuru S, Hofmann TJ, Olson TS, et al. Improved isolation and expansion of bone marrow mesenchymal stromal cells using a novel marrow filter device. Cytotherapy 2013; 15: 146-153.
28. Lin L, Shen Q, Xue T, et al. Heterotopic ossification induced by Achilles tenotomy via endochondral bone formation: Expression of bone and cartilage related genes. Bone 2010; 46: 425-431.
29. Rooney P, Grant ME, McClure J,. Endochondral ossification and de novo collagen synthesis during repair of the rat Achilles tendon. Matrix 1992; 12: 274-281.
30. Nassiri F, Cusimano MD, Scheithauer BW, et al. Endoglin (CD105): A review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Res 2011; 31: 2283-2290.
31. Valluru M, Staton CA, Reed MW, et al. Transforming growth factor-beta and endoglin signaling orchestrate wound healing. Front Physiol 2011; 2: 89.
32. Lee NY, Ray B, How T, et al. Endoglin promotes transforming growth factor beta-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC. J Biol Chem 2008; 283: 32527-32533.
33. Park S, Dimaio TA, Liu W, et al. Endoglin regulates the activation and quiescence of endothelium by participating in canonical and non-canonical TGF-beta signaling pathways. J Cell Sci 2013; 126: 1392-1405.
34. Scherner O, Meurer SK, Tihaa L, et al. Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling. J Biol Chem 2007; 282: 13934-13943.
35. Finnson KW, Parker WL, Chi Y, et al. Endoglin differentially regulates TGF-beta-induced Smad2/3 and Smad1/5 signalling and its expression correlates with extracellular matrix production and cellular differentiation state in human chondrocytes. Osteoarthritis Cartilage 2010; 18: 1518-1527.
36. Daher RJ, Chahine NO, Razzano P, et al. Tendon repair augmented with a novel circulating stem cell population. Int J Clin Exp Med 2011; 4: 214-219.
37. Lui PP, Wong OT,. Tendon stem cells: Experimental and clinical perspectives in tendon and tendon-bone junction repair. Muscles Ligaments Tendons J 2012; 2: 163-168.
38. Sakabe T, Sakai T,. Musculoskeletal diseases-Tendon. Br Med Bull 2011; 99: 211-225.
39. Chaudhury S,. Mesenchymal stem cell applications to tendon healing. Muscles Ligaments Tendons J 2012; 2: 222-229.
40. Ahmad Z, Wardale J, Brooks R, et al. Exploring the application of stem cells in tendon repair and regeneration. Arthroscopy 2012; 28: 1018-1029.
41. Lui PP, Chan KM,. Tendon-derived stem cells (TDSCs): From basic science to potential roles in tendon pathology and tissue engineering applications. Stem Cell Rev 2011; 7: 883-897.
42. Tan Q, Lui PP, Rui YF, et al. Comparison of potentials of stem cells isolated from tendon and bone marrow for musculoskeletal tissue engineering. Tissue Eng Part A 2012; 18: 840-851.
43. Lee NY, Blobe GC,. The interaction of endoglin with beta-arrestin2 regulates transforming growth factor-beta-mediated ERK activation and migration in endothelial cells. J Biol Chem 2007; 282: 21507-21517.